Cipla receives final approval for generic version of GlaxoSmit...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
MUMBAI, India, 02 March 2021 /PRNewswire-AsiaNet/ -- Cipla Limited (BSE: 500087); (NSE: CIPLA EQ) (hereinafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray, 20 mg from the United States Foo...
Authors: LATEST ASIANET NEWS RELEASES
